Sentences with phrase «of embryonic stem cell therapy»

Prop. 71 was sold to voters mainly on the promise of embryonic stem cell therapy.

Zernicka - Goetz's research could also lead to important advancements in the study of embryonic stem cell therapy applications.

A clinical trial in the Republic of Korea for patients with degenerative eye diseases is the first to test the safety of an embryonic stem cell therapy for people of Asian descent.

ACT, which has almost gone under several times in recent years, may now be on the verge of conducting the nation's first trial of an embryonic stem cell therapy, says Chief Scientific Officer Robert Lanza.

Not exact matches

The truth, of course, is that there are no human embryonic stem - cell therapies even in clinical trial, let alone ready for therapy, and there have been no major treatment....

(In many ways it is worse than when John Edwards said in 2004 that if people voted for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from embryonic stem cell therapies.)

The act of reprogramming cells to make them as capable as ones from embryos apparently can result in aberrant cells that age and die abnormally, suggesting there is a long way to go to prove such cells are really like embryonic stem cells and can find use in therapies.

In the past year, the South Korean Food and Drug Administration (FDA) has approved the world's first three stem - cell treatments — Hearticellgram - AMI, Cupistem and Cartistem — which followed on the heels of clinical tests for human embryonic stem - cell therapies approved in 2010, according to the health ministry.

With a history of public blunders, can Advanced Cell Technology make embryonic stem - cell therapies a realCell Technology make embryonic stem - cell therapies a realcell therapies a reality?

The immediate payoff was a commercialization deal in age - related macular degeneration in which Pfizer became the first big pharma company to make a move into the use of embryonic stem cells as the basis for a tissue regeneration therapy.

Finding may enhance understanding of human embryonic stem cells and lead to better models for regenerative therapies

Because the precise activation of Hox genes is essential for a cell's fate, «the research should prove extremely useful in developing novel embryonic stem cell - based therapies, Mazzoni adds.

A fix for broken rat hearts Scientists this week successfully implanted human embryonic stem cells into rats that suffered heart attacks, coming a heartbeat closer to realizing the full potential of such therapy.

Unlike embryonic stem cells, the use of adult stem cells in research and therapy is not controversial because the production of adult stem cells does not require the destruction of an embryo.

Upton lamented «a major gap between the science of cures and the way we regulate these therapies,» and DeGette, an outspoken supporter of human embryonic stem cell research, vowed to «take a comprehensive look» at how Congress might intervene.

In a bid to counteract some of the hype, scientists came to Rockefeller University here last week for a 1 - day conference that offered a clear - eyed look at obstacles that will have to be surmounted before human embryonic stem (ES) cells can be used in therapy.

Adult and embryonic stem cells are complementary subjects of research and studying them side by side offers the greatest potential to rapidly generate new therapies.

After hearing a brief explanation that laid out the different sources of stem cells (but left undiscussed their current uses or future potential for therapy), the respondents offered a slightly more nuanced set of views, and only a slight majority (52 %) supported embryonic stem cell research.

Although we agree that greater investments are needed in the clinical development of these therapies, we disagree with the authors» suggestion that, relative to embryonic stem cells, adult stem cells provide a superior vehicle for cell - based therapies because they lack tumorigenic activity, can be prepared by methods approved by the Food and Drug Administration (FDA), and have been free of ethical controversy.

Derivation of pluripotent stem cells, either of embryonic origin or following genetic reprogramming, has opened the path for an alternative source for epidermal cell therapy as these cells are both immortal and pluripotent, theoretically capable of providing any requested number of cells of any desired phenotype.

For the first time, through the use of human embryonic stem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrostem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrophy.

Not so long ago, human embryonic stem cell (hESC) research and SCNT were being hailed as the future of regenerative medicine, capable of generating cures and therapies for any number of diseases and conditions.

After many delays, the first FDA - approved experiment in people of a therapy made using human embryonic stem cells began in October.

At present, there are no embryonic stem - cell treatments approved by the US Food and Drug Administration, and most human studies of such therapies have shown unremarkable results.

Improved production of retinal cells from embryonic stem cells brings this therapy closer to the clinic.

Embryonic stem (ES) cells are important tools in the study of gene function and may also become important in cell therapy applications.

This approach to derive patient - specific Embryonic Stem cell - like cells (iPS cells) is going to open up research into the genetic causes of disease and the search for therapies not only for such diseases, but also for repairing tissues damaged in other ways.

In addition, we use our expertise to facilitate the development of functionally mature beta cells from embryonic stem cells for cell replacement therapies of type 1 diabetes.

Virtually identical to human embryonic stem cells (hESCs) except for their origin of isolation, the recently created induced pluripotent stem cells (iPSCs)(Yu et al., 2007; Takahashi et al., 2007) hold much potential for use in regenerative therapies.

It's no accident, for instance, that both early studies of embryonic stem - cell therapies — those of Geron and Advanced Cell — involved cells of the nervous syscell therapies — those of Geron and Advanced Cell — involved cells of the nervous sysCell — involved cells of the nervous system.

Jaenisch believes they will eventually succeed and points out that the technique could eventually yield a bountiful supply of custom human embryonic stem cells for use in therapy.

«Having a very efficient and practical way of generating patient - specific stem cells, which unlike human embryonic stem cells, wouldn't be rejected by the patient's immune system after transplantation brings us a step closer to the clinical application of stem cell therapy,» says Belmonte, PhD., a professor in the Gene Expression Laboratory and director of the Center of Regenerative Medicine in Barcelona, Spain.

Lanza's dream of turning human embryonic stem cells into therapies for the sick and the suffering is taking a huge step closer to reality.

Patient - specific stem cells may offer an alternative to embryonic stem cells that will skirt the need for immunosuppressive therapy as well as the social and political ramifications of embryonic stem cell research, but their utility extends far beyond such groundbreaking advances and will assist future clinical practice and patient care.

Late last year the preeminent firm in the field, Silicon Valley's Geron, abdicated its leadership position in the midst of the first - ever FDA - approved clinical trial for an embryonic - stem - cell therapy.

Professor Elly Tanaka and her research group at the DFG Research Center for Regenerative Therapies Dresden — Cluster of Excellence at the TU Dresden (CRTD) demonstrated for the first time the in vitro growth of a piece of spinal cord in three dimensions from mouse embryonic stem cells.

Stem cells come in several varieties some with ethical considerations and Dr. Garner has «Respect all Life» as one of his guiding principles so embryonic stem cell therapy is not an option at SafStem cells come in several varieties some with ethical considerations and Dr. Garner has «Respect all Life» as one of his guiding principles so embryonic stem cell therapy is not an option at Safstem cell therapy is not an option at Safari.